title: Gestational nicotine exposure regulates expression of AMPA and NMDA receptors and their signaling apparatus in developing and adult rat hippocampus.
abstract: Untimely activation of nicotinic acetylcholine receptors (nAChRs) by nicotine results in short- and long-term consequences on learning and behavior. In this study, the aim was to determine how prenatal nicotine exposure affects components of glutamatergic signaling in the hippocampus during postnatal development. We investigated regulation of both nAChRs and glutamate receptors for AMPA and N-methyl-D-aspartate (NMDA), from postnatal day 1 (P1) to P63 after a temporally restricted exposure to saline or nicotine for 14 days in utero. We analyzed postsynaptic density components associated with AMPA receptor (AMPAR) and NMDA receptor (NMDAR) signaling: calmodulin (CaM), CaM Kinase II alpha (CaMKIIα), and postsynaptic density-95 (PSD95), as well as presynaptically localized synaptosomal-associated protein 25 (SNAP25). At P1, there was significantly heightened expression of AMPAR subunit GluR1 but not GluR2, and of NMDAR subunits NR1, NR2a, and NR2d but not NR2b. NR2c was not detectable. CaM, CaMKIIα, and PSD95 were also significantly upregulated at P1, together with presynaptic SNAP25. This enhanced expression of glutamate receptors and signaling proteins was concomitant with elevated levels of [³H]epibatidine (³H]EB) binding in prenatal nicotine-exposed hippocampus, indicating that α4β2 nAChR may influence glutamatergic function in the hippocampus at P1. By P14, neither [³H]EB binding nor the expression levels of subunits GluR1, GluR2, NR1, NR2a, NR2b, NR2c, or NR2d seemed changed with prenatal nicotine. However, CaMKIIα was significantly upregulated with nicotine treatment while CaM showed downregulation at P14. The effects of nicotine persisted in P63 young adult brains which exhibited significantly downregulated GluR2, NR1, and NR2c expression levels in hippocampal homogenates and a considerably muted overall distribution of [³H]AMPA binding in areas CA1, CA2 and CA3, and the dentate gyrus. Our results suggest that prenatal nicotine exposure can regulate the glutamatergic signaling system throughout postnatal development by enhancing or inhibiting availability of AMPAR and NMDAR or their signaling components. The persistent depression, in adults, of the requisite NR1 subunit for NMDAR assembly, and of GluR2, important for assembly, trafficking, and biophysical properties of AMPAR, indicates that nicotine may alter ionotropic glutamate receptor stoichiometry and functional properties in adults after prenatally restricted nicotine exposure.
authors: Department of Anatomy, Howard University College of Medicine, Washington, DC 20059, USA.
authors: H
authors: H
authors: Wang
authors: M I
authors: MI
authors: Dávila-García
authors: W
authors: W
authors: Yarl
authors: M C
authors: MC
authors: Gondré-Lewis
references: Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15488-93
references: 15494439
references: J Comp Neurol. 2005 Jan 3;481(1):19-30
references: 15558717
references: J Neurotrauma. 2008 Oct;25(10):1207-16
references: 18986222
references: Nature. 1995 Jun 1;375(6530):400-4
references: 7760933
references: J Comp Neurol. 1985 Sep 8;239(2):237-46
references: 4044938
references: Brain Res Dev Brain Res. 2002 Dec 15;139(2):175-87
references: 12480132
references: Brain Res Dev Brain Res. 2001 Apr 30;127(2):123-33
references: 11334999
references: Int J Dev Neurosci. 1989;7(3):301-8
references: 2756848
references: Nihon Yakurigaku Zasshi. 1993 Dec;102(6):355-69
references: 8282267
references: Science. 1998 Jan 9;279(5348):222-6
references: 9422694
references: Brain Res Bull. 2007 May 30;72(4-6):215-24
references: 17452284
references: Eur J Pharmacol. 2010 Aug 25;640(1-3):87-93
references: 20457149
references: Neuron. 2004 Sep 30;44(1):5-21
references: 15450156
references: Hippocampus. 2008;18(9):955-64
references: 18493930
references: Int J Dev Neurosci. 1991;9(3):281-6
references: 1656708
references: Neuropharmacology. 1996 Jun;35(6):725-34
references: 8887981
references: Pharmacol Biochem Behav. 2000 Jul;66(3):495-500
references: 10899361
references: Cell Tissue Res. 2006 Nov;326(2):439-46
references: 16862427
references: Perspect Dev Neurobiol. 1998;5(4):401-25
references: 10533528
references: Neurosci Res. 1995 Jan;21(3):199-209
references: 7753501
references: Curr Opin Pediatr. 2008 Apr;20(2):184-90
references: 18332716
references: Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16661-6
references: 20817852
references: Science. 1999 Apr 2;284(5411):162-6
references: 10102820
references: Nutrition. 2005 Jun;21(6):775-7
references: 15925305
references: J Physiol. 1995 Jun 1;485 ( Pt 2):383-402
references: 7545230
references: Pharmacol Biochem Behav. 1998 Feb;59(2):313-8
references: 9476975
references: Nature. 1993 Jan 7;361(6407):31-9
references: 8421494
references: Life Sci. 1987 Apr 27;40(17):1699-708
references: 3561170
references: Environ Health Perspect. 1999 Dec;107(12):991-1000
references: 10585903
references: Neuroscience. 1994 Apr;59(3):541-59
references: 8008208
references: J Neurosci. 2007 Oct 24;27(43):11651-62
references: 17959808
references: Brain Res Dev Brain Res. 1998 Jul 1;109(1):67-75
references: 9706392
references: J Neurosci. 2001 Oct 15;21(20):8154-63
references: 11588188
references: J Neurosci. 2008 Dec 17;28(51):13918-28
references: 19091980
references: Science. 1994 Dec 16;266(5192):1881-5
references: 7997883
references: J Neurosci. 2002 Apr 15;22(8):3005-15
references: 11943803
references: J Neurochem. 1996 Mar;66(3):1240-8
references: 8769890
references: Psychiatr Neurol Neurochir. 1971 Nov-Dec;74(6):433-42
references: 5166176
references: Mol Pharmacol. 1994 Jan;45(1):142-9
references: 8302273
references: Neuroscience. 2006 Jun 19;140(1):163-75
references: 16542781
references: J Neurosci. 1997 Aug 15;17(16):6179-88
references: 9236229
references: Neurochem Res. 1989 Jun;14(6):511-5
references: 2569677
references: Neurotoxicol Teratol. 1999 Sep-Oct;21(5):603-9
references: 10492395
references: Neuroscience. 1983 Dec;10(4):1185-201
references: 6320048
references: Nature. 1996 May 2;381(6577):71-5
references: 8609991
references: Annu Rev Neurosci. 2002;25:103-26
references: 12052905
references: Mol Interv. 2003 Oct;3(7):386-403
references: 14993460
references: Neuron. 1994 Mar;12(3):529-40
references: 7512349
references: Psychopharmacology (Berl). 2009 Jan;202(1-3):103-9
references: 18716760
references: Biochem Soc Trans. 2010 Apr;38(2):460-5
references: 20298203
references: J Comp Neurol. 1993 Jun 1;332(1):69-88
references: 7685781
references: J Am Acad Child Adolesc Psychiatry. 2001 Jun;40(6):630-41
references: 11392340
references: Brain Res Brain Res Rev. 1998 May;26(2-3):243-57
references: 9651538
references: Ann N Y Acad Sci. 1998 Jun 21;846:262-76
references: 9668413
references: J Neurochem. 2003 Jun;85(5):1237-46
references: 12753083
references: Brain Res. 2001 Sep 28;914(1-2):166-78
references: 11578609
references: Trends Neurosci. 2009 Oct;32(10):532-7
references: 19733923
references: Br J Pharmacol. 2002 Sep;137(1):49-61
references: 12183330
references: Electrophoresis. 2006 Jul;27(14):2844-5
references: 16688701
references: Neuropharmacology. 2007 Apr;52(5):1256-62
references: 17320916
references: Mol Pharmacol. 1995 Oct;48(4):774-82
references: 7476906
references: Dev Neurosci. 2001;23(2):107-12
references: 11509833
references: J Neurophysiol. 2000 Sep;84(3):1573-87
references: 10980028
references: J Physiol. 2007 Mar 15;579(Pt 3):753-63
references: 17204496
references: J Neurosci. 1995 Mar;15(3 Pt 1):1912-39
references: 7891142
references: J Neurosci Methods. 2008 Jul 30;172(2):250-4
references: 18571732
references: Nature. 1995 Mar 2;374(6517):65-7
references: 7870173
references: Brain Res Mol Brain Res. 2001 Nov 1;95(1-2):27-35
references: 11687274
references: Brain Res Dev Brain Res. 1997 Aug 18;102(1):117-26
references: 9298240
references: Prog Neurobiol. 2002 Oct;68(3):209-45
references: 12450488
references: Neurobiol Learn Mem. 2008 Oct;90(3):527-36
references: 18662793
references: PLoS One. 2009 Jun 23;4(6):e6021
references: 19547754
references: J Cell Sci. 2011 Mar 1;124(Pt 5):735-44
references: 21321327
references: Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2059-64
references: 12582205
references: J Neurochem. 2002 Aug;82(3):468-81
references: 12153472
references: Mol Pharmacol. 1995 Aug;48(2):280-7
references: 7651361
references: Nat Rev Mol Cell Biol. 2001 Feb;2(2):98-106
references: 11252968
references: J Neurosci. 2006 May 17;26(20):5309-19
references: 16707783